Cai et al. recently discovered that the augmentation of HCC cell glycolysis by circular RHBBD1 restrained PD-1-targeted therapy through increased PIK3R1 translation induced by YTHDF1 [109]. The gene discussed is YTHDF1; the disease is hepatocellular carcinoma.